marijuana stocks

Cara reports 4Q loss

Cara Therapeutics posts loss of $4.2 million in 4th quarter

SHELTON, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Thursday reported a fourth-quarter loss of $4.2 million, after reporting a profit in the same period a year earlier.

The Shelton, Connecticut-based company said it had a loss of 18 cents per share.

The biotechnology company posted revenue of $914,000 in the period.

For the year, the company reported that its loss widened to $17.7 million, or 85 cents per share. Revenue was reported as $3.2 million.

Cara shares have fallen nearly 7 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.30, a drop of 45 percent in the last 12 months.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA

_____

Keywords: Cara Therapeutics, Earnings Report


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$PMCB Pancreatic Cancer Treatment Moves Into a Clinical Trial

PharmaCyte Biotech Outlines 2016 Milestones as Its Pancreatic Cancer Treatment Moves Into…

Cannabis Science, Inc. (CBIS) Negotiates Licensing and Marketing Deals in Canada and the USA to Develop and Sell CBN Products

Independent Valuation of U.S. Patent Number 9,763,991 for Cannabinol (CBN) Initiated as…

HEXO Corp (HEXO) Announces Appointment of John K. Bell as Chair of Board of Directors

HEXO Announces Appointment of John K. Bell as Chair of Board of…

Aurora Cannabis Inc. (ACBFF) Receives First Cannabis Import Permit from Polish Ministry of Health

Aurora Cannabis Receives First Cannabis Import Permit from Polish Ministry of Health…